Correlation Between Microsoft and Amneal Pharmaceuticals,

Can any of the company-specific risk be diversified away by investing in both Microsoft and Amneal Pharmaceuticals, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and Amneal Pharmaceuticals, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Microsoft and Amneal Pharmaceuticals, Class, you can compare the effects of market volatilities on Microsoft and Amneal Pharmaceuticals, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of Amneal Pharmaceuticals,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and Amneal Pharmaceuticals,.

Diversification Opportunities for Microsoft and Amneal Pharmaceuticals,

0.18

Correlation Coefficient

Microsoft  Amneal Pharmaceuticals,

Average diversification

The 3 months correlation between Microsoft and Amneal is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and Amneal Pharmaceuticals, Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amneal Pharmaceuticals, and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with Amneal Pharmaceuticals,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amneal Pharmaceuticals, has no effect on the direction of Microsoft i.e., Microsoft and Amneal Pharmaceuticals, go up and down completely randomly.

Pair Corralation between Microsoft and Amneal Pharmaceuticals,

Given the investment horizon of 90 days Microsoft is expected to under-perform the Amneal Pharmaceuticals,. But the stock apears to be less risky and, when comparing its historical volatility, Microsoft is 1.3 times less risky than Amneal Pharmaceuticals,. The stock trades about -0.33 of its potential returns per unit of risk. The Amneal Pharmaceuticals, Class is currently generating about -0.07 of returns per unit of risk over similar time horizon. If you would invest  873.00  in Amneal Pharmaceuticals, Class on November 29, 2024 and sell it today you would lose (30.00) from holding Amneal Pharmaceuticals, Class or give up 3.44% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Microsoft  vs.  Amneal Pharmaceuticals, Class

Microsoft

Risk-Adjusted Performance

Very Weak

Over the last 90 days Microsoft has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Microsoft is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Amneal Pharmaceuticals,

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Amneal Pharmaceuticals, Class are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Amneal Pharmaceuticals, is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Microsoft and Amneal Pharmaceuticals,

The main advantage of trading using opposite Microsoft and Amneal Pharmaceuticals, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, Amneal Pharmaceuticals, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amneal Pharmaceuticals, will offset losses from the drop in Amneal Pharmaceuticals,'s long position.

The idea behind Microsoft and Amneal Pharmaceuticals, Class pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.